David Powell

Title: David Powell - Innovator in Microfluidic Technology

Introduction

David Powell is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of microfluidics, particularly in the development of devices that enhance the efficiency of biological sample analysis. His innovative work has led to the granting of a patent that showcases his expertise and creativity.

Latest Patents

David Powell holds a patent for "Microfluidic devices and arrangements for supplying such devices with reagents and biological samples." This invention discloses a microfluidic device that includes a reagent supply apparatus. The device features a solid support formed preferably from cellulose fibrous material, which has a porosity that allows liquid flow through the material. It also includes at least one generally dry reagent stored on a surface of the support at designated reagent locations. Furthermore, the support is suitable for storing biological sample material in a dry state at sample locations, which are spaced from the reagent locations. This innovative design enhances the functionality and versatility of microfluidic devices.

Career Highlights

David Powell is currently employed at Global Life Sciences Solutions Operations UK Ltd. His role at the company allows him to work on cutting-edge technologies that advance the field of life sciences. With a focus on innovation, he continues to contribute to the development of solutions that address complex challenges in biological research and diagnostics.

Collaborations

David collaborates with talented individuals in his field, including Jeffrey Kenneth Horton and Simon Laurence John Stubbs. These partnerships foster a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

David Powell's contributions to microfluidic technology exemplify the spirit of innovation in the life sciences sector. His patent and ongoing work at Global Life Sciences Solutions Operations UK Ltd. highlight his commitment to advancing scientific research and improving diagnostic methods.